As of August 28, 2026, Stoke Therapeutics, Inc. (STOK) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. Stoke Therapeutics, Inc. has a market capitalization of $1.93B, 64.53M shares outstanding, 198 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for STOK.
Market Data
Market Cap$1.93B
Shares Outstanding64.53M
Float46.76M
Cash$110.00M
Debt$3.42M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 23.2% shares (2026Q1 vs prior)
198 institutional holders · 83.85M shares
#1
MORGAN STANLEY
10.51M shares
#2
RTW INVESTMENTS, LP
5.62M shares
#3
BlackRock, Inc.
5.39M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest15.81M
Days to Cover27.7
% of Float33.8%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track STOK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking STOK — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for STOK
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.